亚洲知识产权资讯网为知识产权业界提供一个一站式网上交易平台，协助业界发掘知识产权贸易商机，并与环球知识产权业界建立联系。无论你是知识产权拥有者正在出售您的知识产权，或是制造商需要购买技术以提高操作效能，又或是知识产权配套服务供应商，你将会从本网站发掘到有用的知识产权贸易资讯。

返回搜索结果

MRGPRX4 Receptor Agonists and Antagonists

总结: New drug target for treating open and closed wounds as well as chronic pain and itc

技术优势: New drug target for several diseases, e.g.
Neuropathic pain
Itching
Skin inflammation
Chronic pain
Open wounds &
Closed wounds

技术应用: The technology embodies potent and selective MRGPRX4 receptor agonists and antagonists, that may especially be used for treating pain and inflammatory conditions, such as neuropathic or chronic pain, itch, skin diseases, immune diseases, and cancer.

详细技术说明: The MRGPRX (mas-related G protein-coupled receptor X) subfamily is only expressed in primates including humans and belongs to the group of orphan receptors, for which the cognate agonists are unknown.
The human MRGPRX4 receptor represents a fundamentally new drug target, and the development of potent MRGPRX4 receptor agonists, partial agonists, and antagonists / inverse agonists to be used for the treatment of MRGPRX4-associated conditions, disorders or diseases requires the design of novel drugs.

欲了解更多信息，请点击这里